Mauro Magnani (Hrsg.)

Erythrocyte Engineering for Drug Delivery and Targeting

Herausgegeben:Magnani, Mauro

• Gebundenes Buch

Produktbeschreibung

Red Blood Cell Loading: A Selection of Procedures.- Towards Activated Release of Payloads from Carrier Erythrocytes.- Targeting Drug Loaded Red Blood Cells.- Streptavidin-Mediated Coupling of Therapeutic Proteins to Carrier Erythrocytes.- Vaccination Strategy Using Red Blood Cells as Antigen Delivery System.- Engineered Nanoerythrocytes as a Novel Drug Delivery System.- Red Blood Cells as Carriers of Antiviral Agents.- Erythrocytes as Carriers of Anthracycline Antibiotics in vitro and in vivo .- Drug-Loaded Red Blood Cells for the Control of the Inflammatory Response: Selective Targeting of Nuclear Factor-kB (NF-kB).- Design and Synthesis of New Pro-Drugs to be Used with Carrier Red Blood Cells.- Engineered Red Blood Cells as Circulating Bioreactors.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Biotechnology Intelligence Unit 6
• Verlag: Landes Bioscience / Springer / Springer Netherlands / Springer US
• Artikelnr. des Verlages: 978-0-306-47691-4
• 2003
• Seitenzahl: 164
• Erscheinungstermin: 31. Januar 2003
• Englisch
• Abmessung: 235mm x 157mm x 14mm
• Gewicht: 517g
• ISBN-13: 9780306476914
• ISBN-10: 0306476916
• Artikelnr.: 21387643

Inhaltsangabe

Red Blood Cell Loading: A Selection of Procedures.- Towards Activated Release of Payloads from Carrier Erythrocytes.- Targeting Drug Loaded Red Blood Cells.- Streptavidin-Mediated Coupling of Therapeutic Proteins to Carrier Erythrocytes.- Vaccination Strategy Using Red Blood Cells as Antigen Delivery System.- Engineered Nanoerythrocytes as a Novel Drug Delivery System.- Red Blood Cells as Carriers of Antiviral Agents.- Erythrocytes as Carriers of Anthracycline Antibiotics in vitro and in vivo.- Drug-Loaded Red Blood Cells for the Control of the Inflammatory Response: Selective Targeting of Nuclear Factor-kB (NF-kB).- Design and Synthesis of New Pro-Drugs to be Used with Carrier Red Blood Cells.- Engineered Red Blood Cells as Circulating Bioreactors.